1. Home
  2. CJMB vs TENX Comparison

CJMB vs TENX Comparison

Compare CJMB & TENX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CJMB
  • TENX
  • Stock Information
  • Founded
  • CJMB 2007
  • TENX 1967
  • Country
  • CJMB United States
  • TENX United States
  • Employees
  • CJMB N/A
  • TENX N/A
  • Industry
  • CJMB
  • TENX Biotechnology: Pharmaceutical Preparations
  • Sector
  • CJMB
  • TENX Health Care
  • Exchange
  • CJMB NYSE
  • TENX Nasdaq
  • Market Cap
  • CJMB 24.6M
  • TENX 21.6M
  • IPO Year
  • CJMB 2025
  • TENX N/A
  • Fundamental
  • Price
  • CJMB $4.95
  • TENX $5.95
  • Analyst Decision
  • CJMB
  • TENX Strong Buy
  • Analyst Count
  • CJMB 0
  • TENX 3
  • Target Price
  • CJMB N/A
  • TENX $16.00
  • AVG Volume (30 Days)
  • CJMB 12.4K
  • TENX 44.3K
  • Earning Date
  • CJMB 08-15-2025
  • TENX 08-12-2025
  • Dividend Yield
  • CJMB N/A
  • TENX N/A
  • EPS Growth
  • CJMB N/A
  • TENX N/A
  • EPS
  • CJMB N/A
  • TENX N/A
  • Revenue
  • CJMB $6,222,268.00
  • TENX N/A
  • Revenue This Year
  • CJMB N/A
  • TENX N/A
  • Revenue Next Year
  • CJMB N/A
  • TENX N/A
  • P/E Ratio
  • CJMB N/A
  • TENX N/A
  • Revenue Growth
  • CJMB N/A
  • TENX N/A
  • 52 Week Low
  • CJMB $3.38
  • TENX $2.80
  • 52 Week High
  • CJMB $7.76
  • TENX $7.89
  • Technical
  • Relative Strength Index (RSI)
  • CJMB N/A
  • TENX 51.83
  • Support Level
  • CJMB N/A
  • TENX $5.62
  • Resistance Level
  • CJMB N/A
  • TENX $6.35
  • Average True Range (ATR)
  • CJMB 0.00
  • TENX 0.46
  • MACD
  • CJMB 0.00
  • TENX 0.01
  • Stochastic Oscillator
  • CJMB 0.00
  • TENX 41.49

About CJMB CALLAN JMB INC

Callan Jmb Inc is a vertically integrated logistics and fulfillment company that provides cryogenic logistics solutions to the life sciences industry through a combination of proprietary packaging, information technology, and specialized cold chain logistics know-how. It provides a system that utilizes predictive technology to revolutionize the supply chain by guaranteeing the safety, effectiveness, and potency of every product handled to ensure product integrity and to provide immediate response in industries while ensuring environmental responsibility. The company views its solutions as disruptive to the older technologies of dry ice and liquid nitrogen in that its solutions are comprehensive and combine its competencies in configurations that are customized to its clients.

About TENX Tenax Therapeutics Inc.

Tenax Therapeutics Inc is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. The company owns North American rights to develop and commercialize levosimendan and has released topline data regarding the Phase 2 clinical trial for the use of levosimendan in the treatment of pulmonary hypertension associated with Heart Failure and preserved Ejection Fraction.

Share on Social Networks: